OM1 expands its presence in Europe to strengthen support for life sciences through real-world evidence solutions powered by AI
- kenashman
- May 8
- 1 min read
By ET Bureau 13 March 2025
OM1, a leading provider of real-world data (RWD) and AI-powered analytics for life sciences, today announced its expansion into Europe. This move aims to better support pharmaceutical organizations and healthcare stakeholders with high-quality, AI-powered real-world evidence (RWE) solutions. This expansion represents a major step forward in OM1’s mission to improve healthcare decision-making by delivering more actionable, data-driven analytics at an expanded geographic scale.
OM1's expansion into Europe addresses the growing demand for validated, AI-powered real-world evidence, while also addressing the need for rigorous observational research to guide drug development, market access, and regulatory decision-making. By consolidating its presence in Europe, OM1 aims to better support international life sciences companies in defining successful clinical and commercial strategies.
